Today marks a defining moment for Dinmar Labs: we have closed our first institutional funding round. This investment will take Dinmar's technology to the next level — scaling our platform, expanding clinical trials and growing our teams in Baltimore and Oxford.
Why now
Over the past three years, a small team has proven out a vision that started with a single idea. We've built 3D machine-vision models for CT and MRI, created a trusted data pipeline, signed partnerships with two major universities and launched a prospective multi-site clinical study. Investors recognized that we've moved from concept to evidence.
"When I started Dinmar Labs, I believed machine vision could help clinicians find disease earlier. Our team has shown that it can. This funding lets us bring that capability to many more patients."
— Roger Dinmar, Founder & CEOHow we'll use the funding
- Clinical evidence. Expanding our trials with our university partners and adding new indications.
- Regulatory pathway. Building the quality management system and documentation required for regulatory submissions.
- Product & integration. Hardening our platform for deployment inside hospital networks and PACS workflows.
- Team. Hiring across machine learning, clinical science, engineering and regulatory affairs in both offices.
Thank you
To our early supporters, grant reviewers, university partners and new investors: thank you for believing in what we're building. And to our team — this is your achievement.
Explainable AI: Heatmaps That Show Their Work